Page 1 of 4 No. RJH – SET 7/2018 11 May 2018 Subject : Management’s Discussion and Analysis for the 1st quarter of 2018 ending March 31, 2018 To : The President The Stock Exchange of Thailand
MDA Q2_2018 (Eng.) August 7, 2018 Subject : Interim Management Discussion and Analysis of Q2/2018 Attention : President of The Stock Exchange of Thailand We attach herewith the financial statements
Management Discussion and Analysis, Q2/2018 Page 1/3 Ref: IR61/014 10 August 2018 Subject: Management Discussion and Analysis, 2nd Quarter Ending 30 June 2018 To : President The Stock Exchange of
ที่ บช NO. AC.004/2018 13 November 2018 Subject: Clarification of changes in operating performance of more than 20% To: The President of the Stock Exchange of Thailand M.K. Real Estate Development
Page 1 of 4 No. RJH – SET 16/2019 11 November 2019 Subject : Management’s Discussion and Analysis for the 3rd Quarter of 2019 To : The President The Stock Exchange of Thailand Rajthanee Hospital
Microsoft Word - MD&A Q1_2020 (Eng ) May 8, 2020 Subject : Interim Management Discussion and Analysis of Q1/2020 Attention : President of The Stock Exchange of Thailand We attach herewith the
Page 1 of 4 No. RJH – SET 9/2020 10 August 2020 Subject : Management’s Discussion and Analysis for the Second Quarter of 2020 To : The President The Stock Exchange of Thailand Rajthanee Hospital
April 27th, 2021 No. ACC/HO 008/64 Topic: Management Discussion and Analysis for the Quarter of 1/2021 To: President The Stock Exchange of Thailand During the first quarter of 2021 a new wave of
August 11, 2020 Subject: Management’s Discussion and Analysis for the second Quarter of 2020 To: The President The Stock Exchange of Thailand (SET) DOD Biotech Public Company Limited and its subsidiaries
-9320 1 Ref: PCL 2020/018 November 14, 2020 Subject: Management Discussion and Analysis for the 9-month period ended 30 September 2020 To: The President of the Stock Exchange of Thailand Panjawattana